CN105267171B - 盐酸伊托必利组合物 - Google Patents
盐酸伊托必利组合物 Download PDFInfo
- Publication number
- CN105267171B CN105267171B CN201510656016.2A CN201510656016A CN105267171B CN 105267171 B CN105267171 B CN 105267171B CN 201510656016 A CN201510656016 A CN 201510656016A CN 105267171 B CN105267171 B CN 105267171B
- Authority
- CN
- China
- Prior art keywords
- itopride hydrochloride
- pvp
- sustained release
- silica gel
- magnesium stearate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510656016.2A CN105267171B (zh) | 2015-10-13 | 2015-10-13 | 盐酸伊托必利组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510656016.2A CN105267171B (zh) | 2015-10-13 | 2015-10-13 | 盐酸伊托必利组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105267171A CN105267171A (zh) | 2016-01-27 |
CN105267171B true CN105267171B (zh) | 2019-07-12 |
Family
ID=55137577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510656016.2A Active CN105267171B (zh) | 2015-10-13 | 2015-10-13 | 盐酸伊托必利组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105267171B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013032206A1 (ko) * | 2011-08-31 | 2013-03-07 | 한국유나이티드제약 주식회사 | 이토프라이드 염산염을 함유하는 제어 방출성 경구 제제의 조성물 및 그의 제조방법 |
-
2015
- 2015-10-13 CN CN201510656016.2A patent/CN105267171B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013032206A1 (ko) * | 2011-08-31 | 2013-03-07 | 한국유나이티드제약 주식회사 | 이토프라이드 염산염을 함유하는 제어 방출성 경구 제제의 조성물 및 그의 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
CN105267171A (zh) | 2016-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2009335766B2 (en) | Extended-release pharmaceutical formulations | |
CN101647797B (zh) | 一种含有苯磺酸氨氯地平和缬沙坦的药物组合物及其制备方法 | |
BRPI0714915A2 (pt) | composiÇço farmacÊuticas; formas de dosagem farmacÊutica; e processo para o preparo de uma composiÇço farmacÊutica | |
EP3981400A1 (en) | Oral capsule and preparation method therefor | |
US20220249491A1 (en) | Oral solid tablet comprising bruton's tyrosine kinase inhibitor and preparation method therefor | |
AU2013365715B2 (en) | A pharmaceutical composition containing candesartan cilexetil and amlodipine | |
CN106176771B (zh) | 一种拉米夫定-替诺福韦复方片及其制备方法 | |
US8187635B2 (en) | Pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof | |
CN104758265B (zh) | 一种雷诺嗪缓释片药物组合物及其制备方法 | |
CN109875972B (zh) | 一种奥美沙坦酯氨氯地平药物组合物 | |
EA036288B1 (ru) | Фармацевтические лекарственные формы | |
US20130146496A1 (en) | Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation | |
CN102764254B (zh) | 一种左乙拉西坦药物组合物及其制备方法 | |
CN105395506B (zh) | 一种盐酸可乐定缓释片 | |
CN107412198A (zh) | 盐酸度洛西汀肠溶缓释颗粒剂及其制备方法 | |
WO2013189305A1 (zh) | 缬沙坦氨氯地平复方固体制剂及其制备方法 | |
TWI721946B (zh) | 色瑞替尼調配物 | |
CN105267171B (zh) | 盐酸伊托必利组合物 | |
CN108324697B (zh) | 一种含枸橼酸莫沙必利的胶囊剂及其制备方法 | |
EP3539536A1 (en) | A pharmaceutical composition of sunitinib or its salt thereof in its polymorphic form i | |
CN102697749A (zh) | 盐酸贝那普利片的制备方法 | |
JP2018090510A (ja) | デュロキセチン塩酸塩を含む口腔内崩壊錠 | |
CN102688196B (zh) | 一种含有奥美拉唑的颗粒及其制备方法 | |
CN106692094A (zh) | 一种罗拉匹坦药物口服制剂及其制备方法 | |
CN103768034A (zh) | 一种含有盐酸安非他酮的缓控释固体组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191106 Address after: 264205 No. 1 South Qingdao Road, Weihai economic and Technological Development Zone, Shandong, China Co-patentee after: Dijia Pharmaceutical Group Co.,Ltd. Patentee after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Address before: 264205 -1-4 South Road, Weihai economic and Technological Development Zone, Shandong, Qingdao Patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210701 Address after: No.1 Qingdao South Road, Weihai Economic and Technological Development Zone, Shandong Province Patentee after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Address before: No.1 Qingdao South Road, Weihai Economic and Technological Development Zone, Shandong Province Patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Patentee before: Dijia Pharmaceutical Group Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Itopride hydrochloride composition Effective date of registration: 20220721 Granted publication date: 20190712 Pledgee: Bank of China Limited Weihai Branch Pledgor: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Registration number: Y2022980010828 |